Oncology CT

>

Latest News

Are CT and MRI-Derived LI-RADS Assessments Effective for Detecting HCC in Cases of Non-Cirrhotic Chronic Hepatitis C?
Are CT and MRI-Derived LI-RADS Assessments Effective for Detecting HCC in Cases of Non-Cirrhotic Chronic Hepatitis C?

March 31st 2025

LI-RADS category 5 (LR-5) assessment had an 11 percent higher AUC for detecting hepatocellular carcinoma (HCC) in patients with non-cirrhotic chronic hepatitis C (CHC) in comparison to those with cirrhotic CHC.

CT Study: Modified Lung-RADS Model Offers Enhanced Prognostic Assessment of Pure Ground-Glass Nodules
CT Study: Modified Lung-RADS Model Offers Enhanced Prognostic Assessment of Pure Ground-Glass Nodules

March 26th 2025

FDA Grants 510(k) Clearance for New Class of Photon-Counting CT Scanners
FDA Grants 510(k) Clearance for New Class of Photon-Counting CT Scanners

March 10th 2025

Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients
Imaging Findings Reveal 49 Percent Improvement in Progression-Free Survival for Ivonescimab in NSCLC Patients

March 7th 2025

What is the Best HCC Staging System for People Being Treated with Transarterial Chemoembolization (TACE)?
What is the Best HCC Staging System for People Being Treated with Transarterial Chemoembolization (TACE)?

March 5th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.